Enchondroma versus Low-Grade Chondrosarcoma in Appendicular Skeleton: Clinical and Radiological Criteria by Ferrer-Santacreu, Eugenio M. et al.
Hindawi Publishing Corporation
Journal of Oncology
Volume 2012, Article ID 437958, 6 pages
doi:10.1155/2012/437958
Clinical Study
Enchondroma versus Low-Grade Chondrosarcoma in
AppendicularSkeleton:ClinicalandRadiological Criteria
Eugenio M. Ferrer-Santacreu,1 EduardoJ. Ortiz-Cruz,1
Jos´ eM an uelGo n z´ alez-L´ opez,1 andEliaP´ erez Fern´ andez2
1Unidad de Tumores Musculoesquel´ eticos, Servicio de Cirug´ ıa Ortop´ edica y Traumatolog´ ıa, Hospital Universitario La Paz,
Paseo de la Castellana 261, 28046 Madrid, Spain
2Departamento de Bioestad´ ıstica, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046 Madrid, Spain
Correspondence should be addressed to Eduardo J. Ortiz-Cruz, eortiz@mdanderson.es
Received 3 October 2011; Revised 1 February 2012; Accepted 6 February 2012
Academic Editor: Peter E. Schwartz
Copyright © 2012 Eugenio M. Ferrer-Santacreu et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Objectives. To determine the validity of clinical and radiological features of enchondroma and low grade chondrosarcoma, and
contrast the biopsy results with the clinical diagnosis based on the history and imaging. Material and Method. The study included
96 patients with cartilage type lesions suggestive of an enchondroma (E) or an low grade chondrosarcoma (LGC) according to the
clinical and imaging data. The hypotheses were contrasted with the biopsy. Results. Of the 82 patients studied completely, 56 were
considered E (68.29%), 8 as LGC (8.33%) and in 18 (18.75%) were doubtful cases and considered as suspected LGC. Of these, the
biopsy showed 4E (25%), 10LGC (50%) and 4 were not deﬁnitive. On the other hand, of the 56 cases diagnosed as E, 15 were
biopsied, 5 of these biopsies turned out to be LGC (33.3%). The 8 cases diagnosed as LGC, were also biopsied and only 4 biopsies
(50%) conﬁrmed the initial diagnosis. Features analyzed in the study showed no statistically signiﬁcant diﬀerence. Correlation
analysis between the diagnosis issued initially and the biopsy result gave a value of 0.69 (kappa coeﬃcient), which was considered
a good correlation. Conclusion. Features analyzed did not have any statistical signiﬁcance. However, there was a good correlation
between initial diagnosis and biopsy’s result.
1.Introduction
Bone tumors diagnosis includes many radiological, epidemi-
ological, pathological, and clinical considerations. Those
including patient questioning, physical examination, and
radiology will give some hints towards the ﬁnal diagnosis.
But, most of the time, a specimen must be obtained in order
to guarantee an accurate conﬁrmation. However, in some
cases, it is not easy to decide what kind of malignancy we are
treating even with a biopsy. It is in those situations that clini-
cal and radiological data become extremely important when
making a decision on treatment strategies. Among cartilage
tumors, two entities can be misleading for the pathologist
whentryingtoreachacorrectdiagnosis:enchondroma(E),a
benign tumor, and low grade chondrosarcoma (LGC), which
isalow-aggressivitymalignancy.Thiscanbeaproblemwhen
deciding treatment because E only requires regular followup
but LGC needs surgical treatment. The goals of the present
study are ﬁrst, to determine the existence of statistical sig-
niﬁcance between clinical and radiological criteria (obtained
from physical examination, plain radiographs, computerized
tomography (CT), magnetic resonance (MRI), bone scan
with Tc99) and biopsy results; secondly, to ﬁnd the correla-
tion degree between surgeon’s initial impression considering
onlyclinicalandradiologicaldataandpathologist’sdiagnosis
on the biopsy. Clinical, radiological, and histological data of
both E and LCG are summarized in Table 1.
2.MaterialandMethods
We have performed a prospective study in which 96 patients
treated by the authors in our institution. On that purpose,
databases from the institution and from the Pathology
Department of the biggest center were used. All studied2 Journal of Oncology
Table 1: Compared clinical, radiological and histological features of enchondroma and low grade chondrosarcoma.
Enchondroma Low-grade chondrosarcoma
(i) Younger patients (casual ﬁnding in adults) (i) Patients over 25 years old
History and physical
examination
(ii) Seldom painful (ii) Inﬂammatory pain
(iii) Appendicular skeleton almost exclusively (iii) In axial skeleton, a chondral tumor is always
(when in phalanx, E almost 100%) a chondrosarcoma until the opposite is proven
(iv) In general size <5cm (iv) Tends to be bigger than 5cm
(i) Normally intramedullary (i) Intramedullary
(except for enchondroma protuberans)
(ii) No periosteal reaction (ii) periosteal reaction and associated microfractures
Imaging (iii) No endosteal scalloping (or minimal) (iii) Frequent endosteal scalloping
(iv) No changes during the followup (iv) Changes over time, such as calciﬁcations
disappearance, indicating malignization
(v) No soft tissue mass (v) Soft tissue mass
(i) Typical encasement pattern (i) Invades Haversian system
(ii) No endosteal scal loping (ii) periosteal reaction with endosteal scalloping
Biopsy (iii) Multinodular aspect (iii) Ocasional necrotic and haemorraghical focii
(iv) Surrounded by lamellar bone (iv) Invades bone marrow
(v) Does not invade bone marrow (v) Generally a single mass
patients showed a cartilage-type lesion suggesting E or LGC
on plain radiographs. Further imaging (CT, MRI, and Tc99
bone scan) was performed making an initial impression by
the orthopaedic surgeons, which was compared to the ﬁnal
diagnosis (E or LGC) made by the pathologist. Exclusion cri-
teria were established as follows: patients less than 18 years
old, multiple enchondromatosis or multiple osteochondro-
matosis, chondrosarcomas on previous osteochondromas,
cartilage lesions in hands or axial skeleton, and grade II and
III chondrosarcomas according to Evans’ classiﬁcation.
For each patient, a form was fulﬁlled with clinical and
radiological information, including personal data, treating
center, physical examination, symptoms (focusing on pain),
and followup. Age was divided in two categories, under 35
and 35 or older. In plain radiographs, tumor site, side, and
aﬀected bone segment., size and calciﬁcations (changes over
time) were recorded. In CT, size, calciﬁcations (presence and
changesovertime),endostealscalloping,andsofttissuemass
(STM)wereregistered.InMRI,size,endostealscallopingand
STMwerealsorecorded.ConcerningTc99bonescan,lesions
were classiﬁed according to the presence of radionuclide
uptake on whole-body image. The degree of uptake was
compared to anterior iliac crest activity (similar, lower, or
higher than iliac crest physiological uptake) focusing on
anterosuperior iliac crest, as recorded by nuclear medicine
specialistsintheirreports.Ineachcase,aninitialdiagnosis(E
or LGC) was made according to the clinical and radiological
data. Finally, a record of the pathology (type of procedure
and result) was made after pathologist’s reports, conﬁrming
or not surgeon’s initial judgment. Those cases considered in-
itially as E were classiﬁed in the E group if no changes in
clinical and radiological data were recorded after 5 years,
even if the biopsy was not performed.
Statistical analysis was performed by a member of the
Statistics Department. Microsoft Excel and SPSS software
were employed to obtain P values and correlation between
initial diagnosis and histological results (kappa coeﬃcient).
Documentation and references were gathered by means
of PubMed and Ovid search tools using “enchondroma ver-
sus low-grade chondrosarcoma” and “chondral tumors di-
agnosis” as keywords. Articles older than 20 years were dis-
carded, except those considered classic keystones on the mat-
ter.
3. Results
As a whole, data from 96 patients have been analyzed, 22
men and 73 women. Most of the patients showing an E
after the biopsy were women (92.9%), so happened with
LGC (88.9%); hence, sex was not an statistically signiﬁcant
factor in our study. Mean age was 50.82 years, and 84.4%
of the patients were more than 35 years old. Distribution of
E and LGC between the two age groups (younger than 35
and 35 and older) was almost equal (50%/50% for E and
41.4%/58.6% for LGC). No relationship was found con-
cerning patient’s age. Most common location was the femur
(52.1% of the cases) with no clear predominance of any side
(48.3% in right side and 58.5% in the left side). Metaphysis
was the most common segment aﬀected: 28.1% proximal,
especially in the humerus, and 25.8% distal, especially in the
femur. None of these features was statistically related to E or
LGC, comparing them to the biopsies. Concerning the size of
themass,71.2%weresmallerthan5cm.Allbiopsiesshowing
E were less than 5cm. But only 50% of those showing LGC
were smaller than 5cm. Even with these diﬀerences, no
statistical signiﬁcance was found between size and ﬁnalJournal of Oncology 3
(a) (b)
Figure 1: Cartilage lesion in proximal tibia in which calciﬁcations changed over time (A1994 image B 2000 image).
diagnosis (P>0.05 in Fisher’s exact test). According to reg-
istries in our study 44.7% of the cases were incidental ﬁnd-
ings and 55.3% were found after a patient’s consultation
because of pain or other symptoms as discomfort. None of
these situations showed any statistical signiﬁcance with the
ﬁnal diagnosis. 40% of the patients complaining of pain at
the ﬁrst visit were ﬁnally diagnosed as E and 60% as LGC.
Only 14.3% of the patients undergoing a biopsy had no pain
at all. Pain was not an statistically signiﬁcant factor in our
study. 69.2% of the patients belonging to the E group and
61.2% of the LGC group complained of mechanical pain; so
this feature was neither considered as statistically signiﬁcant.
In physical examination, all patients from E group and
94.4% from the LGC group had tenderness in the surround-
ing area. This fact was not statistically signiﬁcant.
All lesions included in our study showed some degree of
calciﬁcation. In two cases, these calciﬁcations suﬀered lysis
within a previously calciﬁed area over time (Figures 1(a) and
1(b)). In 60% of the E patients, 70.6% of the LGC cortical
resorption was seen on CT. Most of the time, it aﬀected one
third of the cortical or even less (30% of E and 64.7% of the
LGC). No soft tissue masses (STMs) were found on CT in
our study. On MRI, 25% of the E and 52.4% of the LGC
showed endosteal scalloping. As on CT, most of the cases
aﬀected one third or less of the cortical, 16.7% of the E and
42.9% of the LGC. There was one case showing STM (only
detected on MRI) in a patient who was ﬁnally diagnosed as
LGC. None of these results on CT and MRI was statistically
signiﬁcant in our study even if there were some diﬀerences.
Concerning bone scan, all patients showed active lesions for
both diagnosis. 60% of the E had the uptake level similar
to anterosuperior iliac crest, 30% showed more uptake, and
10% less uptake. Among LGC patients, 52.9% had the same
uptake, 41.2% had more uptake, and 5.9% had less uptake.
No statistical diﬀerences were found in these data.
Concerning the type of procedure performed in order
to obtain specimens in each patient, the distribution is as
follows: 8 percutaneous core-needle biopsies, 8 incisional
biopsies, and 22 excisional procedures (intralesional wide
resectionwithadjuvanttherapy).In3cases,oneinconclusive
core-needle biopsy had to be conﬁrmed by an incisional
procedure. There were no statistical diﬀerences analyzing the
degree of correlation (kappa coeﬃcient) according to the
type of procedure performed. A reason for this is the small
amount of patients in each category except for incisional and
excisional procedures.
Initially, 56 out of 82 patients were considered as E
(68%), 8 as LGC (8%), and in 18 cases (18%) it was impossi-
ble to obtain a clear judgment. They were included in the
group considered as clinical and radiological suspicion of
LGC. All of them underwent a biopsy. Of these, 4 turned out
to be E (25%), 10 were diagnosed as LGC (50%), and the
other 4 were inconclusive pathologies (in case of doubt they
were treated as LGC). On the other hand, 15 out of 56 cases
judged initially as E and 15 underwent a biopsy. The reason
why we obtained a specimen from a lesion initially con-
sidered as E was changes on the physical examination (pain
or loss of function) or imaging (calciﬁcation lysis or endo-
steal scalloping). Five of them were ﬁnally classiﬁed as LGC
after pathology’s results. The 8 cases judge initially as LGC
underwent a biopsy and only 4 conﬁrmed that diagnosis
(50%). After all these results, Kappa coeﬃcient showed a
value of 0.69, which is considered a moderate degree of cor-
relation between surgeon’s initial judgment and pathology’s
ﬁnal result.
4. Discussion
Diﬀerentiation between E and LGC remains a challenge
for those physicians involved in musculoskeletal oncology4 Journal of Oncology
care [1–3]. Even if other diagnosis must be included in the
diﬀerential (osteomielitis, bone infarction, aneurismal bone
cyst) E and LGC are undoubtedly at the top of the list. In
addition, there is not much consistent data published on this
topicalthoughinitialjudgmentinthesepatientsiscriticalfor
correct decision making on diagnosis and treatment.
Orthopaedic surgeons have three treatment options: fol-
lowup by sequential clinical assessment and radiographic
evaluation for patients with cartilage lesions having a benign
aspect. Next option is performing a biopsy. There are two
kinds of procedures: percutaneous biopsy, performed with
a core-needle device, and incisional biopsy. The third op-
tion is surgical intervention to obtain the whole specimen;
excisional biopsy with adjuvants could be performed. The
mostappropriateprocedureandreconstructionisstillamat-
ter of discussion among specialists. Some prefer to perform
an “en bloc” resection while others think that intralesional
wide resection is a good option considering morbidity and
recurrence rate. Intralesional wide resection includes open-
ing alargecorticalwindow tovisualizethewholetumor,cur-
ettageassociatedwithhigh-speedburring,andtheremaining
cavity is supported by some adjuvant therapies as a lavage
withahigh-pressurepulsatilesystem,phenolization,orcryo-
surgery.Finally, the bone defectis packed with PMMA.Mak-
ing the right choice in each case is a matter of an accurate
initial diagnosis with medical history, physical examination,
and radiological imaging.
In our search, the most complete article in this matter is
the study by Murphey et al. [4] in which the authors analyze
clinical and radiological features in 187 patients (92 E and
95 C). Among all features studied, they found that older
patients, bigger size, endosteal scalloping involving two-
thirdsofthecortexormore(consideringdepthbutnotwidth
of the scalloping), presence of a soft tissue mass, broken
cortices or periosteal reaction in CT or MRI, and uptake
higher than iliac crest physiological uptake in bone scan
strongly suggested the diagnosis of a LGC. Their comparison
is made between enchondromas and chondrosarcomas of all
grades; that must be the reason why they ﬁnd so many rele-
vant diﬀerences. in our study, we focused our analysis on E
versus LGC trying to deﬁne clinical and radiological criteria
between these speciﬁc two entities, because intermediate and
high grade do not represent such a problem in general.
Aswell,Marcoetal.[5]and Weiner[6]describedintheir
reports a general management of benign cartilage tumors
andproposedanalgorithmtoruleoutpossiblemalignancies.
FollowingthemodelofMurphey’sstudy,wehaveintendedto
compare our results to theirs.
Clinical presentation of these tumors is a casual ﬁnding,
when studying the patient for other reasons. In our series
bone metaphysis was the most common site, especially pro-
ximal humerus and distal femur. Presence of pain has always
been related to malignancy or, at least, to a certain degree of
a g g r e s s i v i t y .I nEv e r s u sL G Cd i ﬀerential diagnosis, it should
make us think about LGC. However, it is mandatory to rule
outanyotherpainsourceinthisareabeforethinkingofmali-
gnancies, that is, rotator’s cuﬀ injuries or calciﬁcations in
soft tissue structures of the shoulder, tendinitis, or sprains
if we are focusing on distal femur. If the pain does not show
Figure 2: Cartilage lesion in proximal tibia. Malignancy was sus-
pected because of the size, but it turned out to be an enchondroma
after biopsy.
a mechanical pattern, this might mean that we are dealing
withanactivelesion.Inourseries,painfeatureswerenotsig-
niﬁcantly related to none of both. Murphey et al. [4]f o u n d
statistical signiﬁcance between pain and chondrosarcomas.
Brien et al. [7] recommend for a biopsy every epiphyseal
E in order to distinguish it from a possible chondroblastoma
or a clear cell chondrosarcoma. The diﬀerential diagnosis of
chondroid lesion in the epiphysis includes chondroblastoma,
clear cell chondrosarcoma or even a giant cell tumor, but
not an E because epiphyseal E is very rare in long bones. In
our series, only two epiphyseal lesions were biopsied, one of
them was in distal femur and we did because of pain and
size bigger than 5cm. We thought that it was a LGC and so
showed the pathology. It was treated with an intralesional
wideexcision.Thesecondcasewasintheﬁbularheadandwe
decided to make a biopsy because of pain and an increased
uptake higher than the anterior iliac crest. Pathology was
informed as E but pain persisted so the tumor was resected
and the specimen was classiﬁed ﬁnally as LGC. Same authors
suggest prophylactic intralesional wide resection for patients
under 35 years old and showing a lesion bigger than 7cm.
considering there is an important risk of malignization all
over the years [7]. In our series, we do not have a single case
in that particular situation but our general recommendation
is to keep annual followup unless any clinical or radiological
change occurs.
On plain radiographs, both tumors have a pop corn-like
appearance altogether with arcs and rings pattern (Figures 2
and 3). Although it is the ﬁrst step for diagnosis and it can
show the cartilage, it was not a useful tool to determine
the real size, calciﬁcation degree, and cortex involvement.
It tended to overestimate the measure because it is only a
bidimensional image. CT scan and MRI imaging are more
accurate when assessing these features (Figure 4). Brien et al.
[7] remarks that E has a nodular appearance whereas LGC
tends to show a single mass appearance. The reason for this
is explained by the fact that E is considered to originate as
cartilageremainingofthephysealplate,whicharestimulated
by some unknown factor. This could be the explanation of
the E being multifocal. In Murphey et al’s series [4], chon-
drosarcomas were more common in metaphyseal location,Journal of Oncology 5
Figure 3: Cartilage lesion occupying epiphysis, metaphysis and di-
aphysis. Biopsy showed an LGC.
Figure 4: MRI of the same lesion showing cortical damage and soft
tissue mass.
but E was more common in diaphysis. In our study, both tu-
mors were equally common in metaphyseal locations.
In MRI and CT scan, Murphey found statistical signif-
icance between chondrosarcomas and common features of
malignancy: endosteal scalloping involving more than two-
thirds of cortices depth, soft tissue mass, breaking of the
cortex and periosteal reaction. In our study, we only assessed
howdeepwasthecorticalinvolvement.Wedidnotfoundany
case showing breaking of the cortex and there was one case
of soft tissue mass. Endosteal scalloping aﬀected one third of
the cortex in almost all cases in our series (Figure 6).
Concerning bone scan imaging, malignancies are expect-
ed to have a greater metabolic activity; therefore, LGC
should show more uptake than E. Nevertheless, in some cir-
cumstances, E might show an increased uptake in bone scan:
pathologic fracture, cortical expansion in small bones (not
included in our study) or impingement with other anato-
mical structures next to the tumor site. Murphey could as-
sess these features in 51 patients classifying them in three
categories: (1) less uptake than anterior iliac crest (AIC), (2)
SameuptakethanAIC,(3)GreateruptakethanAIC.Authors
found that 42 out of 51 patients with chondrosarcoma
showed greater uptake than AIC, which was statistically
(a) (b)
Figure 5:Bonescanshowingproximalhumeruscartilagemasswith
an increased uptake higher than anterior iliac crest. It turned out to
be an LGC.
Figure 6: CT scan image showing endosteal scalloping of a distal
femur cartilage lesion. Biopsy showed an LGC.
signiﬁcant(Figure 5).Inourstudy, wedidnotfoundanysta-
tistical signiﬁcance.
Correlation between initial judgment made by the senior
authors and the pathology result showed a Kappa value of
0.69, considered as moderate/good. Our interpretation is
that surgeon’s experience is capital in decision making when
physical examination, imaging, and pathology result do not
help with clear criteria. Senior authors have been focused
on orthopaedic oncology for many years. Altogether with
radiologists, oncologists, radiation oncologists, pathologists
also specialized in bone and soft tissue sarcomas, results in6 Journal of Oncology
a team work that enables a suitable diagnostic and therapeu-
tic strategy even in diﬃcult cases. In our institution, diﬃcult
cases are discussed in multidisciplinary conferences held
weekly with all specialists involved in orthopaedic oncology
patient care. These practices have improved cooperation be-
tween diﬀerent departments and make therapeutic strategies
timing easier for patients and their physicians.
In our understanding, our study showed some weak-
nesses. Only 82 of 96 patients completed the followup. Of
these, only 40 underwent a biopsy. On the other hand, it
is a prospective multicenter study, which is a good basis
for further data collection and analysis. Furthermore, we
only took into consideration type I chondrosarcomas of long
bones, excluding axial skeleton in which LGC is more pro-
bable; and short bones of hands and feet in which E is nearly
always the ﬁnal diagnosis.
5. Conclusions
Benign and low-grade cartilage tumors are not easy to diﬀer-
entiate, and they remain a challenge for physicians in de-
cision making and therapeutic strategies. All specialists in-
volved in orthopaedic oncology can help in diﬀerentiating E
from LGC for a correct treatment. Our study showed no as-
sociation between these two entities and clinical and radi-
ological criteria in patient history, physical examination,
plain radiographs, CT scan, MRI, and bone scan with
Tc99. On the other hand, there was a good correlation be-
tween surgeon’s initial judgment and pathology results. This
enhances the importance of physician’s experience and team
work when dealing with these cases. More patients should be
included to obtain a clear relationship between E and LGC
with any of the analyzed features. We strongly recommend
multidisciplinary assessment of diﬃcult cases in order to
avoidmistakesindecisionmakingwhichcouldleadtowrong
treatments. Maybe, next step in cartilage lesions diﬀerentia-
tion will rely on molecular and genetic tests to clearly deter-
mine what kind of tumor we are treating.
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